Abstract:Abstract Background: Few prospective studies have sufficient power to investigate the relationship between obesity and lethal prostate cancer (PC) in detail or within population subgroups, such as by smoking status. This study aimed to investigate the associations of pre-diagnostic body mass index (BMI) with risk of progression from time of PC diagnosis to fatal outcome, to assess effect modification by smoking status and to evaluate the joint effect of BMI and smoking on PC survival. Methods: We conducted a survival analysis of 10,206 PC patients from the NCI Breast and Prostate Cancer Cohort Consortium (BPC3). BMI and smoking status were estimated before PC diagnosis. Deaths among PC patients were categorized into deaths from PC and other causes. We conducted the analysis in 3 parts according to exposures: BMI (18-22.9 kg/m2, 23-24.9 kg/m2. 25-27.9 kg/m2, 28-29.9 kg/m2, 30-34.9 kg/m2, 35 kg/m2+), smoking (Never, former, current) and their joint effect, respectively. Each analysis was performed on prostate cancer specific mortality and other mortality separately. Competing-risks regression model was used to take into account of other causes of death. For the above analyses, two models were used. Model 1 controlled for age at diagnosis, drinking status, diabetes status, cohort, duration between baseline and PC diagnosis; Model 2 further adjusted for PC stage and Gleason score at diagnosis in addition to model 1. Results: There were 1028 deaths from PC and 1919 other deaths among all PC patients during an average follow up of eight years. Higher BMI was associated with higher risk of death from PC and other causes; compared to BMI (23-24.9 kg/m2) group, men with BMI 35+ kg/m2 had HR=1.83, 1.16-2.91 for PC death and HR=1.49, 1.04-2.14 for other deaths. The positive trend was apparent only among never and former smokers but not current smokers. Similar effect was found among men whose BMI measured >5 years but for men whose BMI was measured <=5 years before PC diagnosis, only those in the highest category (BMI 35+ kg/m2) was associated with higher risk of dying from PC. Former smokers as well as current smokers have significant higher risk of progressing to death after PC diagnosis regardless BMI with significant interaction between BMI and smoking. Conclusions: Higher BMI and smoking history (former and current smokers) are possible risk factors for dying from PC among all PC cases in the BPC3 cohort. The effect of BMI on PC survival is modified by smoking status. Citation Format: Changzheng Yuan, Jorge Chavarro, Sara Lindström, Peter Kraft, Jing Ma. Prediagnostic body-mass index, smoking, and prostate cancer survival. [abstract]. In: Proceedings of the Twelfth Annual AACR International Conference on Frontiers in Cancer Prevention Research; 2013 Oct 27-30; National Harbor, MD. Philadelphia (PA): AACR; Can Prev Res 2013;6(11 Suppl): Abstract nr B49.

BMI changes and the risk of lung cancer in male never‐smokers: A prospective cohort study

Body Mass Index and Mortality: A 10-Year Prospective Study in China

Body mass index and risk of lung cancer: Systematic review and dose-response meta-analysis

Body Mass Index and the Risk of Gastric Cancer in Males: a Prospective Cohort Study

Abstract B49: Prediagnostic Body-Mass Index, Smoking, and Prostate Cancer Survival

Body mass index and risk of gastric cancer: A 30-year follow-up study in the Linxian general population trial cohort.

The causal relevance of body mass index in different histological types of lung cancer: A Mendelian randomization study

Causal relationships between body mass index, smoking and lung cancer: Univariable and multivariable Mendelian randomization

Longitudinal associations between BMI change and the risks of colorectal cancer incidence, cancer-relate and all-cause mortality among 81,388 older adults

Body mass index and incidence of lung cancer in the HUNT study: using observational and Mendelian randomization approaches

Independent And Joint Associations Of Blood Lipids And Lipoproteins With Lung Cancer Risk In Chinese Males: A Prospective Cohort Study

Body mass index and lung cancer risk: Pooled analysis of 10 prospective cohort studies in Japan

Cancer incidence in relation to body fatness among 0.5 million men and women: Findings from the China Kadoorie Biobank

[Prospective Cohort Study on the Relationship Between Smoking Cessation and Cancer Risk in Males].

The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients

Lifelong smoking status, weight gain, and subsequent risk of major adverse cardiovascular events: Long-term follow-up of a middle-aged Chinese population

Association of weight change with all-cause and cause-specific mortality: an age-stratified analysis

Metabolic Obesity Phenotypes and Risk of Lung Cancer: A Prospective Cohort Study of 450,482 UK Biobank Participants

Quantitative Association Between Body Mass Index and the Risk of Cancer: A Global Meta-analysis of Prospective Cohort Studies.

[Anthropometry and the Risk of Colorectal Cancer in Males: a Prospective Cohort Study].

Diet and the Risk of Head-and-neck Cancer among Never-Smokers and Smokers in a Chinese Population.